Julian Zimmermann Timo Buhl Marcus Müller
10.3389/fneur.2017.00569
Front Neurol
2017 Oct 30;8:569.
adverse events alemtuzumab alopecia areata alopecia totalis alopecia universalis autoimmunity multiple sclerosis treatment safety
CC BY
https://pubmed.ncbi.nlm.nih.gov/29163335/
Case Reports
PMC5670499
29163335
Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity-Report of a Case and Review of the Literature
2017